{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:40:58Z","timestamp":1787064058483,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1177\/1933719116635278","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T21:23:16Z","timestamp":1456435396000},"page":"1242-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effects of Exenatide on Metabolie Changes, Sexual Hormones, Inflammatory Cytokines, Adipokines, and Weight Change in a DHEA-Treated Rat Model"],"prefix":"10.1007","volume":"23","author":[{"given":"Lingjun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"12","key":"23091242_CR1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA. Polycystic ovary Syndrome. N Engl J Med. 2005; 352(12):1223\u20131236.","journal-title":"N Engl J Med"},{"issue":"12","key":"23091242_CR2","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, et al.. Diagnosis and treat-ment of polycystic ovary Syndrome:an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565\u20134592.","journal-title":"J Clin Endocrinol Metab"},{"key":"23091242_CR3","first-page":"719050","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas J, Ch\u00e4vez M, Olivar L, et al.. Polycystic ovary Syndrome, insulin resistance, and obesity:navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050.","journal-title":"Int J Reprod Med"},{"issue":"6","key":"23091242_CR4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/humrep\/der065","volume":"26","author":"M Hudecova","year":"2011","unstructured":"Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Poromaa IS. Diabetes and impaired glucose tolerance in patients with polycystic ovary Syndrome - a long term follow-up. Hum Reprod. 2011;26(6):1462\u20131468.","journal-title":"Hum Reprod"},{"issue":"9","key":"23091242_CR5","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","volume":"61","author":"A Gambineri","year":"2012","unstructured":"Gambineri A, Patton L, Altieri P, et al.. Polycystic ovary Syndrome is a risk factor for type 2 diabetes:results from a long-term pro-spective study. Diabetes. 2012;61(9):2369\u20132374.","journal-title":"Diabetes"},{"issue":"4","key":"23091242_CR6","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2005-2327","volume":"91","author":"F Gonzalez","year":"2006","unstructured":"Gonzalez F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor kB Triggers inflammation and insulin resistance in polycystic ovary Syndrome. J Clin Endocrinol Metab. 2006; 91(4):1508\u20131512.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"23091242_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary Syndrome. Mol Cell Endocrinol. 2011;335(1):30\u201341.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"23091242_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2005.10.059","volume":"119","author":"E Carmina","year":"2006","unstructured":"Carmina E, Orio F, Palomba S, et al.. Endothelial dysfunction in PCOS:role of obesity and adipose hormones. Am J Med. 2006; 119(4):356. e1-e6.","journal-title":"Am J Med"},{"issue":"6","key":"23091242_CR9","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","volume":"88","author":"F Orio Jr","year":"2003","unstructured":"Orio F Jr, Palomba S, Cascella T, et al.. Adiponectin levels in women with polycystic ovary Syndrome. J Clin Endocrinol Metab. 2003;88(6):2619\u20132623.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5708","key":"23091242_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M, et al.. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426\u2013430.","journal-title":"Science"},{"issue":"1","key":"23091242_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1684\/ecn.2011.0279","volume":"22","author":"F Cekmez","year":"2011","unstructured":"Cekmez F, Cekmez Y, Pirgon O, et al.. Evaluation of new adipo-cytokines and insulin resistance in adolescents with polycystic ovary Syndrome. Eur Cytokine Netw. 2011;22(1):32\u201337.","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"23091242_CR12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","volume":"94","author":"E Plati","year":"2010","unstructured":"Plati E, Kouskouni E, Malamitsi-Puchner A, Boutsikou M, Kaparos G, Baka S. Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian Stimulation. Fertil Steril. 2010;94(4):1451\u20131456.","journal-title":"Fertil Steril"},{"issue":"10","key":"23091242_CR13","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/der267","volume":"26","author":"KM Seow","year":"2011","unstructured":"Seow KM, Hwang JL, Wang PH, Ho LT, Juan CC. Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary Syndrome. Hum Reprod. 2011;26(10):2869\u20132873.","journal-title":"Hum Reprod"},{"issue":"8","key":"23091242_CR14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. PEDF:a multifaceted neuro-trophic factor. Nat Rev Neurosci. 2003;4(8):628\u2013636.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"23091242_CR15","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/jc.2005-2654","volume":"91","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, Adachi H, Abe A, et al Elevated serum levels of pigment epithelium-derived factor in the metabolic Syndrome. J Clin Endocrinol Metab. 2006;91(6):2447\u20132450.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"23091242_CR16","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.diabres.2008.06.019","volume":"82","author":"A Jenkins","year":"2008","unstructured":"Jenkins A, Zhang SX, Gosmanova A, et al.. Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract. 2008;82(1):e5\u2013e7.","journal-title":"Diabetes Res Clin Pract"},{"key":"23091242_CR17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/jc.2010-2140","volume":"963","author":"S Yang","year":"2011","unstructured":"Yang S, Li Q, Zhong L, et al.. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary Syndrome and correlates with insulin resistance. J Clin Endocrinol Metab. 2011; 96(3):831\u2013836.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"23091242_CR18","first-page":"1626","volume":"86","author":"R Azziz","year":"2001","unstructured":"Azziz R, Ehrmann D, Legro RS, et al.. Troglitazone improves Ovulation and hirsutism in the polycystic ovary Syndrome:a mul-ticenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;86(4):1626\u20131632.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"23091242_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00001703-200412000-00008","volume":"16","author":"J Lord","year":"2004","unstructured":"Lord J, Wilkin T. Metformin in polycystic ovary Syndrome. Curr Opin Obstet Gynecol. 2004;16(6):481\u2013486.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"23091242_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0133","volume":"157","author":"F Orio","year":"2007","unstructured":"Orio F, Manguso F, Di Biase S, et al.. Metformin administration improves leukocyte count in women with polycystic ovary Syndrome:a 6-month prospective study. Eur J Endocrinol. 2007; 157(1):69\u201373.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"23091242_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","volume":"117","author":"LL Nielsen","year":"2004","unstructured":"Nielsen LL, Young AA, Parkes DG. Pharmacologyofexenatide (synthetic exendin-4):a potential therapeutic for improved glyce-mic control of type 2 diabetes. Regul Pept. 2004;117(2):77\u201388.","journal-title":"Regul Pept"},{"issue":"3","key":"23091242_CR22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2009.10.015","volume":"390","author":"T Kim Chung le","year":"2009","unstructured":"Kim Chung le T, Hosaka T, Yoshida M, et al.. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression. Biochem Biophys Res Commun. 2009;390(3):613\u2013618.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"23091242_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/JOE-09-0132","volume":"202","author":"S Kim","year":"2009","unstructured":"Kim S, Moon M, Park S. Exendin-4 protects dopaminergic neu-rons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson\u2019s disease. J Endocrinol. 2009;202(3):431\u2013439.","journal-title":"J Endocrinol"},{"issue":"1","key":"23091242_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1095\/biolreprod64.1.157","volume":"64","author":"H Hemmi","year":"2001","unstructured":"Hemmi H, Endo T, Nagasawa K, et al.. Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod. 2001;64(1):157\u2013162.","journal-title":"Biol Reprod"},{"issue":"6","key":"23091242_CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u20131495.","journal-title":"Diabetes Care"},{"issue":"8","key":"23091242_CR26","first-page":"3146","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell AS, Middleton LJ, Jimenez M, et al.. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary Syndrome in female hyperandrogenic mouse modeis. Endo-crinology. 2014;155(8):3146\u20133159.","journal-title":"Endo-crinology"},{"issue":"1-2","key":"23091242_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2012.10.007","volume":"373","author":"AS McNeilly","year":"2013","unstructured":"McNeilly AS, Dimcan WC. Rodent modeis for human polycystic ovary Syndrome. Mol Cell Endocrinol. 2013;373(1-2):2\u20137.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"23091242_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09513590.2014.975686","volume":"31","author":"B Artimc-Ulkumen","year":"2015","unstructured":"Artimc-Ulkumen B, Pala HG, Pala EE, Yavasoqlu A, Yiqtturk G, Erbas O. Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats. Gynecol Endocrinol. 2015;31(3):196\u2013201.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"23091242_CR29","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","volume":"90","author":"LR Harborne","year":"2005","unstructured":"Harborne LR, Sattar N, Norman JE, Fleming R. Metformin and weight loss in obese women with polycystic ovary Syndrome:comparison of doses. J Clin Endocrinol Metab. 2005;90(8):4593\u20134598.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"23091242_CR30","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"K Elkind-Hirsch","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight-women with polycystic ovary Syndrome. J Clin Endocrinol Metab. 2008;93(7):2670\u20132678.","journal-title":"J Clin Endocrinol Metab"},{"key":"23091242_CR31","first-page":"1223","volume-title":"N Engl J Med","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA. Polycystic ovary Syndrome. N Engl J Med. 2005; 352(12):1223\u20131236."},{"issue":"7","key":"23091242_CR32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obe-sity and the polycystic ovary Syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883\u2013896.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"23091242_CR33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM DeUgarte","year":"2005","unstructured":"DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary Syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454\u20131460.","journal-title":"Fertil Steril"},{"issue":"6","key":"23091242_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.endonu.2010.04.001","volume":"57","author":"D Quintero-Castillo","year":"2010","unstructured":"Quintero-Castillo D, Luz-Araujo H, Guerra-Vel\u00e4zquez M, et al.. Lipid profile in obese and non-obese women with polycystic ovary Syndrome treated with metformin. Endocrinol Nutr. 2010; 57(6):262\u2013267.","journal-title":"Endocrinol Nutr"},{"issue":"13","key":"23091242_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.medcli.2011.10.025","volume":"139","author":"P Pujante Alarc\u00f6n","year":"2012","unstructured":"Pujante Alarc\u00f6n P, Hellin Gil MD, Roman LM, Ferrer G\u00f6mez M, Garcia Zafra MV, Tebar Mass\u00f6 J. Metabolie control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide. Med Clin (Bare). 2012;139(13):572\u2013578.","journal-title":"Med Clin (Bare)"},{"issue":"5","key":"23091242_CR36","doi-asserted-by":"crossref","first-page":"r219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunetion, adipokines, and low-grade chronic inflammation in polycystic ovary Syndrome. Reproduction. 2015; 149(5):r219\u2013r127.","journal-title":"Reproduction"},{"issue":"10","key":"23091242_CR37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1463-1326.2007.00832.x","volume":"10","author":"L Li","year":"2008","unstructured":"Li L, Yang G, Li Q, et al.. Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels. Diabetes Obes Metab. 2008;10(10):921\u2013930.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"23091242_CR38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1139\/cjpp-2012-0300","volume":"91","author":"G Derosa","year":"2013","unstructured":"Derosa G, Cicero AF, Franzetti IG, et al.. Effects of exenatide and metformin in combination on some adipocytokine levels:a comparison with metforminmonotherapy. Can J Physiol Pharmacol. 2013;91(9):724\u2013732.","journal-title":"Can J Physiol Pharmacol"},{"key":"23091242_CR39","first-page":"429207","volume-title":"Mediators Inflamm","author":"S Yang","year":"2013","unstructured":"Yang S, Lv Q, Luo T, et al.. Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPKphosphorylation. Mediators Inflamm. 2013;2013:429207."},{"issue":"1","key":"23091242_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","volume":"97","author":"A Chaudhuri","year":"2012","unstructured":"Chaudhuri A, Ghanim H, Vora M, et al.. Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab. 2012;97(1):198\u2013207.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116635278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719116635278","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719116635278\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719116635278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116635278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T21:49:06Z","timestamp":1656798546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719116635278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["23091242"],"URL":"https:\/\/doi.org\/10.1177\/1933719116635278","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"1 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}